{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:32:16Z","timestamp":1781757136886,"version":"3.54.5"},"reference-count":58,"publisher":"Microbiology Society","issue":"9","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,30]]},"abstract":"<jats:p>Invasive pneumococcal disease remains one of the leading causes of morbidity and mortality worldwide. In Russia, 13- valent pneumococcal conjugate vaccine (PCV13) was introduced into the childhood immunization programme nationwide in 2014. As part of the Global Pneumococcal Sequencing Project (GPS), we used genome data to characterize 179 pneumococcal isolates collected from Russia in 2011\u20132018 to investigate the circulating pneumococcal strains using a standardized genomic definition of pneumococcal lineages (global pneumococcal sequence clusters, GPSCs), prevalent serotypes and antimicrobial resistance profiles.<\/jats:p>\n               <jats:p>We observed high serotype and lineage diversity among the 179 isolates recovered from cerebrospinal fluid (<jats:italic>n<\/jats:italic>=77), nasopharyngeal swabs (<jats:italic>n<\/jats:italic>=99) and other non-sterile site swabs (<jats:italic>n<\/jats:italic>=3). Overall, 60 GPSCs were identified, including 48 clonal complexes (CCs) and 14 singletons, and expressed 42 serotypes (including non-typable). Among PCV13 serotypes, 19F, 6B and 23F were the top three serotypes while 11A, 15B\/C and 8 were the top three among non-PCV13 serotypes in the collection. Two lineages (GPSC6 and GPSC47) expressed both PCV13 and non-PCV13 serotypes that caused invasive disease, and were penicillin- and multidrug-resistant (MDR), highlighting their potential to adapt and continue to cause infections under vaccine and antibiotic selective pressure. PCV13 serotypes comprised 92\u200a% (11\/12) of the CSF isolates from the children aged below 5\u2009years; however, the prevalence of PCV13 serotype isolates dropped to 53\u200a% (31\/58) among the nasopharyngeal isolates. Our analysis showed that 59\u200a% (105\/179) of the isolates were predicted to be non-susceptible to at least one class of antibiotics and 26\u200a% (46\/179) were MDR. Four MDR lineages (GPSC1, GPSC6, GPSC10 and GPSC47) accounted for 65\u200a% (30\/46) of the MDR isolates and expressed PCV13 serotypes (93\u200a%, 28\/30).<\/jats:p>\n               <jats:p>This study provides evidence of high genetic and serotype diversity contributed by a mix of globally spreading and regionally circulating lineages in Russia. The observations suggest that the PCV13 vaccine could be important in reducing both invasive disease and antimicrobial resistance. We also identify potential lineages (GPSC6 and GPSC47) that may evade the vaccine.<\/jats:p>","DOI":"10.1099\/mgen.0.000851","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T14:19:23Z","timestamp":1663337963000},"source":"Crossref","is-referenced-by-count":13,"title":["Key features of pneumococcal isolates recovered in Central and Northwestern Russia in 2011\u20132018 determined through whole-genome sequencing"],"prefix":"10.1099","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1096-4324","authenticated-orcid":false,"given":"Ekaterina","family":"Egorova","sequence":"first","affiliation":[{"name":"G. N. Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narender","family":"Kumar","sequence":"additional","affiliation":[{"name":"Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Gladstone","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway"},{"name":"Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Urban","sequence":"additional","affiliation":[{"name":"G. N. Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Voropaeva","sequence":"additional","affiliation":[{"name":"G. N. Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.V.","family":"Chaplin","sequence":"additional","affiliation":[{"name":"G. N. Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rumiantseva","sequence":"additional","affiliation":[{"name":"Labstory Medical Center, Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. S.","family":"Svistunova","sequence":"additional","affiliation":[{"name":"Infectious Clinical Hospital \u2116 2, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina A.","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith P.","family":"Klugman","sequence":"additional","affiliation":[{"name":"Rollins School of Public Health, Emory University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Breiman","sequence":"additional","affiliation":[{"name":"Emory Global Health Institute, Atlanta, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"McGee","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Bentley","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Cambridge, Cambridge, UK"},{"name":"Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie W.","family":"Lo","sequence":"additional","affiliation":[{"name":"Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.04.032"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212295"},{"key":"R3","article-title":"Estimated Hib and pneumococcal deaths for children under 5 years of age [Internet]. www.who.int. 2013 [cited 2019 Jun 10]","year":"2008"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30247-X"},{"key":"R5","article-title":"WHO. Measuring impact of Streptococcus pneumoniae and Haemophilus influenzae type b conjugate vaccination [Internet]. 2012 [cited 2019] p. 10(7):477\u2013477","year":"2012"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30110-8"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30052-5"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00054-2"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.05.065"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy920"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.22341.1"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz178"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.059"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000076"},{"key":"R15","article-title":"Russian Federation: WHO and UNICEF estimates of immunization coverage: 2019 revision [Internet]. https:\/\/www.WHO.int\/. 2020 [cited 2021 Dec 2]","year":"2020"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.15690\/pf.v15i4.1943"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1159363"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2019.114914"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2013.871205"},{"key":"R20","first-page":"11","article-title":"Population pattern of pneumococci with lower susceptibility to penicillin and prospects of antipneumococcal vaccination to control antibiotic resistance distribution","volume":"56","author":"Sidorenko","year":"2011","journal-title":"Antibiot Khimioter"},{"key":"R21","first-page":"10","article-title":"Antibiotic resistance and serotype pattern of Streptococcus pneumoniae Isolated from Children in St. Petersburg in 2010-2013","volume":"60","author":"Kalinogorskaya","year":"2015","journal-title":"Antibiot Khimioter"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-04998-5"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2019.02.010"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.36233\/0372-9311-2020-97-2-113-118"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.04.021"},{"key":"R26","volume-title":"Laboratory Methods for the Diagnosis of Meningitis Caused by Neisseria Meningitidis, Streptococcus Pneumoniae, and Haemophilus Influenzae: WHO Manual, 2nd ed","year":"2011"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.8.2097-2100.1993"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.6.2518-2522.2004"},{"key":"R29","volume-title":"CLSI Supplement M100","year":"2018"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2017.08.004"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1101\/179465"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.21105\/joss.00118"},{"key":"R33","article-title":"GitHub. 2017 [cited 2021]","year":"2017"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.08.001"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-017-4017-7"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1101\/gr.241455.118"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000357"},{"key":"R38","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1196"},{"key":"R39","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu033"},{"key":"R40","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.06.004"},{"key":"R42","article-title":"U.S. FDA Accepts for Priority Review the Biologics License Application for V114, Merck\u2019S Investigational 15-valent Pneumococcal Conjugate Vaccine, for Use in Adults 18 Years of Age and Older","year":"2021"},{"key":"R43","article-title":"U.S. FDA Approves PREVNAR 20TM, Pfizer\u2019s Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years or Older","year":"2021"},{"key":"R44","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis703"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2013.11.005"},{"key":"R46","first-page":"89","article-title":"PDF) problems of treatment and prevention of pneumococcus infection in children","volume":"6","author":"Chernyshova","year":"2018","journal-title":"Actual Infectology"},{"key":"R47","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.es2015.20.13.21079"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1149-8"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.12.028"},{"key":"R50","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001206"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1147-x"},{"key":"R52","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.077"},{"key":"R53","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30297-X"},{"key":"R54","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06103-w"},{"key":"R55","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2019.05.006"},{"key":"R56","article-title":"WHO. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report [Internet]. WHO","year":"2020"},{"key":"R57","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.620002"},{"key":"R58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1721095115"}],"container-title":["Microbial Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/mgen\/10.1099\/mgen.0.000851?crawler=true&mimetype=application\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T18:28:57Z","timestamp":1702578537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/mgen\/10.1099\/mgen.0.000851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9,30]]}},"URL":"https:\/\/doi.org\/10.1099\/mgen.0.000851","relation":{},"ISSN":["2057-5858"],"issn-type":[{"value":"2057-5858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]}}}